X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21869) 21869
Newspaper Article (1912) 1912
Newsletter (1182) 1182
Book Chapter (287) 287
Magazine Article (139) 139
Trade Publication Article (21) 21
Book / eBook (20) 20
Transcript (8) 8
Conference Proceeding (7) 7
Dissertation (7) 7
Web Resource (7) 7
Publication (5) 5
Book Review (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16919) 16919
thromboembolism (14595) 14595
science & technology (13884) 13884
life sciences & biomedicine (13306) 13306
female (8871) 8871
male (7803) 7803
middle aged (6076) 6076
anticoagulants (5828) 5828
aged (5747) 5747
anticoagulants - therapeutic use (5718) 5718
risk factors (5541) 5541
cardiovascular system & cardiology (4782) 4782
thrombosis (4453) 4453
adult (4256) 4256
hematology (3725) 3725
thromboembolism - prevention & control (3719) 3719
venous thromboembolism (3664) 3664
patients (3242) 3242
drug therapy (3114) 3114
treatment outcome (3100) 3100
thromboembolism - drug therapy (3090) 3090
abridged index medicus (3002) 3002
anticoagulants - administration & dosage (2822) 2822
peripheral vascular disease (2810) 2810
research (2751) 2751
care and treatment (2648) 2648
anticoagulants - adverse effects (2633) 2633
cardiac & cardiovascular systems (2496) 2496
general & internal medicine (2368) 2368
thromboembolism - etiology (2328) 2328
health risk assessment (2305) 2305
stroke (2283) 2283
aged, 80 and over (2264) 2264
surgery (2257) 2257
retrospective studies (2079) 2079
medicine, general & internal (2053) 2053
pulmonary embolism (2048) 2048
venous thromboembolism - drug therapy (2026) 2026
venous thromboembolism - prevention & control (2014) 2014
atrial fibrillation (2004) 2004
analysis (1926) 1926
mortality (1912) 1912
warfarin (1871) 1871
cancer (1816) 1816
hemorrhage - chemically induced (1799) 1799
health aspects (1731) 1731
medical research (1728) 1728
administration, oral (1682) 1682
risk assessment (1618) 1618
clinical trials (1616) 1616
prevention (1613) 1613
medicine & public health (1559) 1559
time factors (1523) 1523
cardiovascular diseases (1456) 1456
atrial fibrillation - drug therapy (1420) 1420
bleeding (1419) 1419
incidence (1414) 1414
medicine, experimental (1414) 1414
warfarin - therapeutic use (1413) 1413
prospective studies (1331) 1331
fibrinolytic agents - therapeutic use (1328) 1328
pharmacology & pharmacy (1328) 1328
heparin - therapeutic use (1305) 1305
cardiac arrhythmia (1302) 1302
cardiology (1300) 1300
venous thromboembolism - etiology (1281) 1281
studies (1241) 1241
pregnancy (1224) 1224
oncology (1216) 1216
follow-up studies (1171) 1171
animals (1170) 1170
adolescent (1160) 1160
heparin, low-molecular-weight - therapeutic use (1151) 1151
drug dosages (1144) 1144
embolisms (1144) 1144
anticoagulation (1130) 1130
atrial fibrillation - complications (1128) 1128
medicine (1121) 1121
heparin (1116) 1116
hemorrhage (1090) 1090
recurrence (1055) 1055
venous thrombosis - drug therapy (1040) 1040
pulmonary embolism - drug therapy (992) 992
cardiovascular disease (991) 991
complications and side effects (991) 991
internal medicine (988) 988
hypertension (977) 977
rivaroxaban (941) 941
randomized controlled trials as topic (926) 926
venous thrombosis (919) 919
aspirin (912) 912
young adult (911) 911
hospitals (908) 908
dosage and administration (901) 901
thromboembolism - epidemiology (901) 901
venous thromboembolism - epidemiology (889) 889
veins & arteries (888) 888
stroke - prevention & control (862) 862
dose-response relationship, drug (860) 860
usage (849) 849
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23786) 23786
German (716) 716
French (394) 394
Russian (183) 183
Italian (163) 163
Spanish (141) 141
Japanese (96) 96
Polish (57) 57
Portuguese (52) 52
Hungarian (37) 37
Chinese (33) 33
Danish (31) 31
Czech (28) 28
Norwegian (28) 28
Dutch (25) 25
Swedish (20) 20
Romanian (15) 15
Hebrew (13) 13
Turkish (12) 12
Croatian (10) 10
Serbian (10) 10
Finnish (9) 9
Bulgarian (5) 5
Lithuanian (4) 4
Slovak (4) 4
Korean (3) 3
Ukrainian (3) 3
Slovenian (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 06/2019, Volume 321, Issue 24, pp. 2414 - 2427
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2015, Volume 372, Issue 5, pp. 426 - 435
.... 3 Splenomegaly often develops as the disease progresses. 4 The main goal of therapy is to prevent thrombotic events while avoiding iatrogenic harm and minimizing the risk of transformation to post–polycythemia vera myelofibrosis or acute myeloid leukemia (AML). 5 , 6 Most patients receive low-dose aspirin and undergo phlebotomy, 7 with a goal of maintaining hematocrit values of less than 45%. Aggressive . . . 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pyrazoles - therapeutic use | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Antineoplastic Agents - therapeutic use | Spleen - drug effects | Thrombocytopenia - chemically induced | Remission Induction | Blood Cell Count | Janus Kinases - antagonists & inhibitors | Organ Size - drug effects | Hydroxyurea - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Hydroxyurea - therapeutic use | Polycythemia Vera - drug therapy | Aged | Spleen - pathology | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Spleen | Thrombocytopenia | Splenomegaly | Herpes zoster | Inhibitor drugs | Hematocrit | Polycythemia vera | Hydroxyurea | Thrombosis | Patients | Side effects | Polycythemia | Janus kinase | Remission | Blood diseases | Thromboembolism | Drug therapy | Drug dosages | Nuclear magnetic resonance--NMR | Phlebotomy | Restless legs syndrome | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
.... The risk of bleeding was lower with dabigatran therapy; prevention of thromboembolic events was similar with the two strategies. 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2 Suppl, pp. e691S - e736S
Journal Article
Journal of Crohn's and colitis, ISSN 1876-4479, 02/2013, Volume 7, Issue 1, pp. 1 - 33
Journal Article